Jump to navigation

Morocco

 New travel bans introduced as disputes break out over vaccine certificates

Rabat bars some European visitors amid rising Covid infections and vaccine rules come under scrutiny

After over a year of tight travel restrictions by European states on their Africa counterparts, the boot is on the other foot. Morocco has banned incoming and outbound flights between the Britain, Germany and the Netherlands citing rising Covid-19 cases.

Latest figures from the European Centre for Disease Prevention and Control show that Morocco's weekly rate of reported cases on 14 October stood at 10.4 per 100,000 people. The current rate in Britain is 445.5 per 100,000 people, with Whitehall's Office of National Statistics suggesting infection levels are driven partly by high rates among schoolchildren.

Over 56% of Morocco's population is fully vaccinated, the highest on the continent. That compares to Britain, where 66.6% have received both doses of the vaccine and about 65.3% 68.3% in Germany and the Netherlands respectively.

Travel restrictions and the issue of which vaccines are recognised are frustrating diplomats. New rules in Britain recognise vaccines administered from 108 countries, exempting from quarantine 'fully vaccinated' travellers who have received the vaccines of Oxford/AstraZeneca, Pfizer BioNTech, Moderna or Janssen.

Individuals who have received the same vaccines but from countries not on the approved list are considered 'not fully vaccinated' and forced to quarantine for 10 days on arrival.

African countries in this list include Egypt, Ghana, Kenya, Morocco, Namibia, Nigeria, and South Africa. This raises concerns about vaccine equity but could also reinforce vaccine hesitancy within the African continent.

Most EU countries consider people fully vaccinated and allow free travel within the bloc with an EU-digitised Covid certificate if they have had a single dose of a two-dose vaccination.

The UK's red-list measures have prompted the Kenya's foreign ministry to term the measures 'punitive, discriminatory, divisive and exclusive in character'.

Nairobi officials point out that the Oxford-produced Astra Zeneca vaccine trials were approved by the World Health Organization at the Kilifi Research Centre on Kenya's coast.

They called for continued collaboration including Britain's support for Africa's first genomic surveillance programme in identifying variant strains at Kenya Medical Research Institute's Kilifi facility which operates with support from the Wellcome Trust (AC Dispatches, Rich countries offer funds for future vaccine production but do little this year to get the serum to developing economies).



Related Articles

DISPATCHES

Rich countries offer funds for future vaccine production but do little this year to get the serum to developing economies

Credible plans are in train to establish production centres in Africa but the global inequities in distributions are stark and deadly

On 6 September, Britain's former Prime Minister Gordon Brown told the BBC that the Group of 7 economies would have a billion surplus doses of vaccine by the end of this year. On pr...

READ FOR FREE

Tesler trapped

Officers from Britain’s Serious Fraud Office arrested lawyer Jeffrey Tesler, 60, at his offices in Tottenham in London on 5 March in a move that will widen the international invest...


A win for the Makhzen

The victory for Aziz Akhannouch’s loyal liberal party promises a government the king can count on

When King Mohammed VI (M6) asked billionaire businessman Aziz Akhannouch to form a government, their meeting on 10 September formalised the victory of secular over Islamist faction...


Trading on the fly

The latest leg of British Secretary of State for International Trade Liam Fox's African charm offensive found itself overshadowed when his colleague International Development Secre...


Less bashing for bribers

UK businesses lobbying against the new Bribery Act seem to be having some success (see Confidential Agenda, week ending 28 January). The government has postponed implementation o...